Cancer BiologybioRxivPreprint
CD99Targeted Irinotecan Containing Nanoparticles Show Twenty-Fold Greater Anti-Tumor Effect Than Free Irinotecan For Treatment of EwingSarcoma
Hyung Gyoo Kang, Sheetal A. Mitra, Bryon Upton…·Timothy Triche
This paper evaluates NV103, a CD99-targeted irinotecan nanoparticle, showing 20-fold greater antitumor effect than free irinotecan in Ewing sarcoma with no toxicity.
DOI 10.64898/2026.01.06.697855